Amir Kazory, MD
Nephrology · Gainesville, FLNPI 1447312970
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Nuwellis, Inc. at 40.8% of the total. Reporting peaked in 2020 at $5,415 and has fallen 97.2% since, to $150 in 2024. Among nephrology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 20 payments — averaging $800.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nuwellis, Inc.$7K
- Baxter Healthcare$4K
- Amgen$2K
- Daxor Corporation$1K
- W. L. Gore & Associates, Inc.$900
- Vifor Pharma, Inc.$600
- plus $349 from 2 others
What the payments were for
- Consulting fees$7,01144%
- Speaking & faculty fees$6,27539%
- Travel & lodging$1491%
- Food & beverage$2,37015%
- Entertainment$1991%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nuwellis, Inc. | 7 | $6,525 |
| Baxter Healthcare | 6 | $4,355 |
| Amgen | 1 | $2,075 |
| Daxor Corporation | 1 | $1,200 |
| W. L. Gore & Associates, Inc. | 2 | $900 |
| Vifor Pharma, Inc. | 1 | $600 |
| Quanta Dialysis Technologies Inc | 1 | $199 |
| Mallinckrodt Hospital Products Inc. | 1 | $150 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Aquadex$4,525
- Renal - PD$4,261
- KRYSTEXXA$2,075
- AQUADEX SMARTFLOW CONSOLE$2,000
- BVA-100$1,200
- Product in Development$900
- Veltassa$600
- SC+ Hemodialysis Machine$199
- TERLIVAZ$150
How this compares
$16,004 in reported general payments places this provider in the 90th percentile of 756 nephrology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paricalcitol | 21 | $2,344 |
| Calcitriol | 50 | $892 |
| Lisinopril | 50 | $351 |
| Potassium Chloride | 22 | $257 |
| Losartan Potassium | 21 | $113 |
| Carvedilol | 25 | $88 |
| Hydrochlorothiazide | 16 | $76 |
| Amlodipine Besylate | 16 | $63 |
| Metoprolol Tartrate | 12 | $61 |
| Furosemide | 20 | $59 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Gainesville
- Arvind MadanOrlando$943K
- John CopleyWeston$934K
- Jorge LarranagaKissimmee$825K
- Carlos BejarFort Lauderdale$530K
- Wayne KotzkerFort Lauderdale$472K
- Jason RothschildTemple Terrace$413K
- Daniel PatelDaytona Beach$227K
- Rafael Baez BonillaFort Lauderdale$175K
- Gabriel ContrerasMiami$133K
- Fouad ChebibJacksonville$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.